• search

Nectar Lifesciences raises US$ 35mn through FCCBs

Written by: Staff

Mumbai, Mar 25 (UNI) Nectar Lifesciences Ltd informed BSE that as per the authority granted by the share holders in their Extra Ordinary General Meeting held on December 15 last year, the company had successfully raised US dollar 35 million through Foreign Currency Convertible Bonds (FCCB) on March 2 this year, Deutsche Bank acted as the sole bookrunner to the transaction.

The bonds, which have a maturity of 5 years and 1 day, are convertible at a conversion price of Rs 331.74 per share, which is at a premium of 20.0 per cent over the closing price of Rs 276.45 on the Bombay Stock Exchange on March 24 last year. The bonds are zero coupon bonds with a yield to maturity of 8.375 per cent, calculated on a semi-annual basis, at the end of 5 years if not converted, into shares during this period.

Due to the strong response to the offering, the issue was upsized from US dollar 30 million to US dollar 35 million. The bonds are expected to be listed on the Singapore Exchange Securities Trading Limited.


For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more